Form 4 for OVID Ovid Therapeutics Inc.
Accepted 2025-01-29 00:00:00 ET · period of report 2025-01-27 · accession 0001415889-25-002230 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-29 | 2025-01-27 | OVID | ALEXANDER MARGARET A. | Pres, COO | P - Purchase | $0.73 | +6,810 | 34.9K | +24% | +$4,971 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-27 | P | A | 6,810 | $0.73 | 34,935 | D | — | — |